Sim Farar Joins BioS
Sim Farar Joins BioSig Technologies Advisory Board
08 mai 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, May 08, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies
BioSig Technologies Completes Private Placement
01 mai 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, May 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed...
BioSig Technologies
BioSig Technologies to Partner with High Lantern Group
26 avr. 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, April 26, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform for the $4.6...
Congenital Heart Wal
Congenital Heart Walks Announced in 26 Communities Nationwide in 2018
17 avr. 2018 16h10 HE | Adult Congenital Heart Association
Philadelphia, April 17, 2018 (GLOBE NEWSWIRE) -- To support, honor and remember the millions of children, adults and families impacted by congenital heart disease (CHD), The Children’s Heart...
BioSig Technologies
BioSig Technologies to Present at the MicroCap Conference
06 avr. 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, April 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies
BioSig Technologies Issues 2018 Shareholder Letter
05 avr. 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, April 05, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) a medical device company developing a proprietary biomedical signal processing platform designed to address an...
biosig_rgb.png
BioSig Announces Submission of FDA 510(k) Application for PURE EP System
28 mars 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
biosig_rgb.png
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
28 mars 2018 02h00 HE | BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
biosig_rgb.png
BioSig Technologies Announces Participation in Bates College’s Purposeful Work Initiative
21 mars 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, March 21, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
biosig_rgb.png
Business and Medical Leaders Join BioSig Advisory Board
20 mars 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, March 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...